Literature DB >> 25624032

Prophylactic octreotide in pancreatoduodenectomy: response to Yang et al.

Matthew T McMillan1, Charles M Vollmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25624032      PMCID： PMC4368405          DOI： 10.1111/hpb.12381

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  5 in total

1.  Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy.

Authors:  Uwe J Hesse; Christophe DeDecker; Philippe Houtmeyers; Pieter Demetter; Wim Ceelen; Piet Pattyn; Roberto Troisi; Bernard deHemptinne
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

Review 2.  Postoperative pancreatic fistula: an international study group (ISGPF) definition.

Authors:  Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

3.  Pasireotide for postoperative pancreatic fistula.

Authors:  Peter J Allen; Mithat Gönen; Murray F Brennan; Adjoa A Bucknor; Lindsay M Robinson; Marisa M Pappas; Kate E Carlucci; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Yuman Fong; William R Jarnagin
Journal:  N Engl J Med       Date:  2014-05-22       Impact factor: 91.245

4.  Prophylactic octreotide for pancreatoduodenectomy: more harm than good?

Authors:  Matthew T McMillan; John D Christein; Mark P Callery; Stephen W Behrman; Jeffrey A Drebin; Tara S Kent; Benjamin C Miller; Russell S Lewis; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2014-07-10       Impact factor: 3.647

5.  Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.

Authors:  O Kollmar; M R Moussavian; S Richter; P de Roi; C A Maurer; M K Schilling
Journal:  Eur J Surg Oncol       Date:  2008-03-04       Impact factor: 4.424
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.